• Clinical Study in Miami showed a dramatic increase in tear break up time(TBUT) after only one week of use. Investigator, Dr. Bill Trattler, reported that FRESHKOTE appeared to have a long-lasting positive affect on the ocular surface rather than just temporary relief of symptoms.
• Clinical Trial in Melbourne, Australia by Dr. Grant Mason demonstrated significant improvement in corneal staining and TBUT; with 33% of dry eye patients experiencing total regeneration of the ocular surface epithelial cells. Additional evaluation at largest eye clinic in Japan by Dr. Tsubota reported "The drops seem to be very wonderful".
• Sjogren's and other severe dry eye patients were the subjects of a West Texas clinical trial by Dr. Dave Lamberts; with 100% showing significant improvement in corneal staining, foreign body sensation, mucus discharge, burning & redness .. as compared to the control product (Tears Naturale - Alcon).
• As presented at the Tear Film (TFOS) Conference in November 2004; an unusual and unique "cyber" study was conducted in over 200 patients with post-LASIK dry eye, with a subjective efficacy rating of 90% as compared to all other artificial tears not developed by Dr. Holly.
• In compliance with the FDA Ophthalmic Monograph; cleared by the British MHRA for marketing in the UK; CE Mark certification in November 2006 for all Countries of the EU.
• European Patent Office approves in 2006, with Patent No. 1551417 ... USPTO approves in July 2010 with Patent No. US 7,758,883 B2 ... and patent pending in Brazil.
• Trademark approved in the USA and all countries of the EU.
• Altacor Ltd launches early 2008 in UK/Ireland under the brand: Clinitas Ultra 3.

CONTACT AQUEOUS PHARMA:  joeechols1@gmail.com